Bayesian Capital Management’s TCR2 Therapeutics Inc. Common Stock TCRR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q2
Sell
-11,300
Closed -$31K 1175
2022
Q1
$31K Buy
+11,300
New +$31K ﹤0.01% 743